Hosted on MSN
AI and biosensors reshaping sickle cell diagnosis
From rural clinics to cutting-edge labs, AI and biosensing technologies are revolutionizing how sickle cell disease is detected and monitored. These tools promise faster, more accurate, and more ...
RICHMOND, Va. — September is National Sickle Cell Awareness Month. Sickle cell affects 100,000 people in the United States, primarily impacting African Americans. To learn more about the genetic blood ...
This article is part of “Innovations In: Sickle Cell Disease,” an editorially independent special report that was produced with financial support from Vertex Pharmaceuticals. Sickle cell disease was ...
Exagamglogene autotemcel (exa-cel) is a nonviral cell therapy designed to reactivate fetal hemoglobin synthesis by means of ex vivo clustered regularly interspaced short palindromic repeats ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results